SMALL VESSELS-BIG PROBLEMS IN ALZHEIMER’S DISEASE (ID 2411)

Presenter
Authors
Gallery Display
Onsite Oral and Gallery PDF
Audio MP3

Audio MP3

Hide

Previous ePoster
DETECTION OF TAU ACCUMULATION IN AMYLOID POSITIVE PRECLINICAL AND EARLY AD USING [18F]RO-948, [18F]MK-6240, [18F]GTP1, AND [18F]FLORTAUCIPIR TAU PET TRACERS (ID 2410)

Next ePosters
COMPARISON OF STRUCTURAL AND METABOLIC BIOMARKERS FOR BRAIN AGE PREDICTION USING MACHINE LEARNING (ID 2314)
EEG ABNORMALITIES IN PATIENTS WITH DELIRIUM AS A PREDICTIVE BIOMARKER OF DEMENTIA WITH LEWY BODIES (ID 2315)
VISIT-TO-VISIT BLOOD PRESSURE VARIABILITY PREDICTS CEREBROSPINAL FLUID ALZHEIMER’S DISEASE BIOMARKERS IN OLDER ADULTS (ID 2317)
DATA-DRIVEN SUBTYPING AND POST HOC ANALYSIS OF AZD0530 (FYN) TRIAL (ID 2394)
COGNITIVE SCREENING IN PATIENTS WITH PARKINSONISM: PROPOSAL FOR A NEW, MACHINE LEARNING-BASED DIAGNOSTIC TOOL (ID 2396)
ASSOCIATIONS BETWEEN IRON DEPOSITION IN THE BRAIN AND AD-LIKE NEUROIMAGING PHENOTYPES IN COGNITIVELY UNIMPAIRED ADULTS (ID 2471)
TARGETING REACTIVE ASTROCYTOSIS FOR NOVEL BIOMARKERS OF DISEASE SEVERITY IN MULTIPLE SYSTEM ATROPHY (ID 2359)
PARKINSON’S DISEASE MODIFICATION THROUGH ABL KINASE INHIBITION (ID 2360)
PROTEOMIC CORRELATES OF AMYLOID BETA AND TAU IN CSF. A MONOZYGOTIC TWIN STUDY (ID 2408)
GSK-3ALPHA IN HUNTINGTON’S DISEASE (ID 1797)